AKT1 and prostate cancer: In prostate cancer, high expression of ELOVL2 suggests improved prognosis, and small hairpin RNA targeting ELOVL2 promotes cell proliferation, colony formation, migration and invasion, as well as the growth of subcutaneous xenografts by activating the PI3K/AKT signaling pathway (32).